AzTrials
AzTrials

HC-BPPVPhase 3BPPV-HCNCT00810641

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo

A Phase 3 study testing Gufoni maneuver and Head-shaking maneuver in people with HC-BPPV, run by Chonbuk National University at 2 sites in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to compare the immediate efficacies of each treatment maneuvers in treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo (HC-BPPV). Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
HC-BPPV
What is being tested?
Gufoni maneuver and Head-shaking maneuver
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
157 participants
Where
2 sitesSouth Korea
Study dates
Jan 2009to May 2011
Phase
Phase 3
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • a history of brief episodes of positional vertigo,
  • direction-changing horizontal nystagmus beating toward the uppermost (apogeotropic nystagmus) or undermost (geotropic nystagmus) ear in both the lateral head turning positions,
  • no spontaneous nystagmus during upright sitting position, and
  • absence of identifiable central nervous system disorders that could explain the positional vertigo and nystagmus.

Who cannot join

  • central positional nystagmus with identifiable CNS lesions that could explain the positional nystagmus

Trial locations and contacts

2 sites in 1 country.

South Korea2 sites
  • Chonbuk National University Hospital

    Jeonju, Cholabuk-do, 560-712

  • Seoul National University Bundang Hospital

    Seongnam, Kyoungki-do

Other trials in South Korea

About this study

Official title: Randomized Multicenter Study of Treatment of Horizontal Canal Benign Paroxysmal Positional Vertigo

The purpose of this study was to compare the immediate efficacies of each treatment maneuvers in treatment of apogeotropic horizontal canal benign paroxysmal positional vertigo (HC-BPPV).

Read the detailed description

A randomized prospective study of patients with HC-BPPV. Patients with apogeotropic type of HC-BPPV were randomized to one of each three treatment groups at their first clinic visit. These groups included the Gufoni maneuver, head-shaking maneuver, and sham group in apogeotropic HC-BPPV. Responsiveness of treatment maneuver was determined by positioning maneuver immediately after each treatment method based on resolves of vertigo and positional nystagmus.

Conditions
HC-BPPV
Being tested
Gufoni maneuver, Head-shaking maneuver, sham maneuver
Keywords
BPPV(benign paroxysmal positional vertigo), HC-BPPV(BPPV involving the horizontal semicircular canal), Nystagmus, Treatment outcome, Horizontal Canal Benign Paroxysmal Positional Vertigo
Medical subject headings
Benign Paroxysmal Positional Vertigo, Nystagmus, Pathologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gufoni maneuverProcedure or surgery

    For Gufoni maneuver,16,18 the patient was quickly brought down to the side-lying position on the affected ear from the sitting position. After one minute in this position, the head of the patient was quickly turned 45O upward, so that the nose directed upward. Approximately 2 minutes later, the patient was returned to the upright position (Figure 2A).

  • Head-shaking maneuverProcedure or surgery

    For head-shaking maneuver,15 patients were brought into a sitting position. After pitching the head forward by approximately 30O, we moved the head sideways in a sinusoidal fashion at an approximate rate of 3 Hz for 15 seconds.

  • sham maneuverProcedure or surgery

    For the sham maneuver, patients quickly lied on the unaffected side, and returned to the sitting position after one minute.

Study groups in NCT00810641
Study groupRoleWhat they receive
Gufoni maneuverActive comparatorGufoni maneuver for apogeotropic HC-BPPV
Receives: Procedure: Gufoni maneuver
Headshaking maneuverActive comparatorheadshaking maneuver for apogeotropic HC BPPV
Receives: Procedure: Head-shaking maneuver
sham maneuverSham comparatorsham maneuver for apogeotropic HC BPPV
Receives: Procedure: sham maneuver

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial

    The immediate treatment response was determined by participating neurologists in each clinic without knowing the maneuver applied to each patient from 30 minutes to one hour after initial maneuver. The absence of both vertigo and nystagmus was required to determine a resolution.

    Measured: one hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2008 (estimated)
  2. Study startJan 2009
  3. Primary completionMay 2011
  4. Study completionMay 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
157 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00810641
Sponsor's protocol ID
KONOS
Acronym
BPPV-HC
Status last verified
May 2011
First submitted
17 Dec 2008
Last updated
27 Jun 2011
Data monitoring committee
Yes

Publications

  • Kim JS, Oh SY, Lee SH, Kang JH, Kim DU, Jeong SH, Choi KD, Moon IS, Kim BK, Oh HJ, Kim HJ. Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo. Neurology. 2012 Jan 17;78(3):159-66. doi: 10.1212/WNL.0b013e31823fcd26. Epub 2011 Dec 14.

    PubMed 22170885

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Gufoni maneuver and Head-shaking maneuver in people with HC-BPPV, run by Chonbuk National University at 2 sites in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 27 Jun 2011). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial (time frame: one hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00810641, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in